BioTools Joins Chiral Technologies in Cooperative Agreement
BioTools Inc., of Jupiter Florida, and Chiral Technologies Inc., of West Chester, Pennsylvania, have entered into a cooperative agreement that will provide comprehensive coverage of chirality-related services and technologies ranging from small scale and preparative chromatography to absolute configuration of chiral compounds.
BioTools Inc., of Jupiter Florida, and Chiral Technologies Inc., of West Chester, Pennsylvania, have entered into a cooperative agreement that will provide comprehensive coverage of chirality-related services and technologies ranging from small scale and preparative chromatography to absolute configuration of chiral compounds. The combination of services from the two companies is expected to improve efficiency and understanding in a range of research areas such as drug discovery, drug development, and industrial process.
Although the scope of the agreement has not yet been disclosed, Rina Dukor, president of BioTools said “Entering into this collaborative alliance with Chiral Technologies will provide researchers with a unique blend of services, instruments and technologies to advance the understanding that chiral-based structures play in biological and chemical processes.”
BioTools provides advanced chiroptical instrumentation and services to pharmaceutical companies and academia serving critical areas of biopharmaceutical and chiral drugs research. Chiral Technologies supplies chiral chromatography products and services in North and South America.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
